The developed method of 13C6-Glucose labeling combined with liquid chromatography high-resolution mass spectrometry is versatile and lays the foundation for future studies on the primary organs and pathways involved in the synthesis of secondary metabolites in medicinal plants, as well as the comprehensive utilization of these secondary metabolites.
This paper presents a novel and efficient method for certifying primary organs involved in secondary metabolite synthesis. As the most important secondary metabolite in Parispolyphylla var. yunnanensis (Franch.) Hand. -Mzt. (PPY), Paris saponin (PS) has a variety of pharmacological activities and PPY is in increasing demand. This study established leaf, rhizome, and stem-vascular-bundle 13C6-Glucose feeding and non-feeding four treatments to precisely certify the primary organs involved in Paris saponins VII (PS VII) synthesis. By combining liquid chromatography-mass spectrometry (LC-MS), the 13C/12C ratios of leaf, rhizome, stem, and root in different treatments were quickly and accurately calculated, and four types of PS isotopic ion peak(M−) ratios were found: (M+1) −/M−, (M+2) −/M−, (M+3) −/M− and (M+4) −/M−. The results showed that the ratio of 13C/12C in the rhizomes of the stem-vascular-bundle and rhizome feeding treatments was significantly higher than that in the non-feeding treatment. Compared to the non-feeding treatment, the ratio of PS VII molecules (M+2) −/M− in the leaves increased significantly under leaf and stem-vascular-bundle feeding treatments. Simultaneously, compared to the non-feeding treatment, the ratio of PS VII molecules (M+2) −/M− in the leaves under rhizome treatment showed no significant difference. Furthermore, the ratio of PS VII molecules (M+2) −/M− in the stem, root, and rhizome showed no differences among the four treatments. Compared to the non-feeding treatment, the ratio of the Paris saponin II (PS II) molecule (M+2) −/M− in leaves under leaf feeding treatment showed no significant difference, and the (M+3) −/M− ratio of PS II molecules in leaves under leaf feeding treatment were lower. The data confirmed that the primary organ for the synthesizing of PS VII is the leaves. It lays the foundation for future identification of the primary organs and pathways involved in the synthesis of secondary metabolites in medicinal plants.
The biosynthetic pathways of secondary metabolites in plants are intricate and diverse, involving highly specific and diverse accumulation organs1. At present, the specific synthesis sites and responsible organs for secondary metabolites in many medicinal plants are not well-defined. This ambiguity poses a significant obstacle to the strategic advancement and implementation of cultivation methods designed to optimize both the yield and quality of medicinal materials.
Molecular biology, biochemical, and isotope labeling techniques are extensively employed to unravel the synthesis pathways and sites of secondary metabolites in medicinal plants2,3,4,5, and each of these methodologies exhibits unique strengths and limitations, such as differences in efficiency and accuracy. Molecular biology approaches, for instance, offer high precision in pinpointing the sites within biosynthetic pathways but are notably time-intensive. Their utility is further constrained for species lacking publicly available genomic sequences, rendering these techniques less viable for such cases6. In contrast, isotope labeling techniques, employing isotopic ratios like 3C/12C, 2H/1H, and 18O/16O, provide a rapid and accessible means to investigate the synthesis, transport, and storage mechanisms of secondary metabolites7,8. They can reveal the spatial distribution of organic compounds and stable isotopes in leaves, thereby allowing the reconstruction of environmental conditions experienced by the leaves throughout their life cycle9. Furthermore, the application of external isotopic labels, such as 13C6-Glucose10 and 13C6-Phenylalanine11, enables the generation of carbon-labeled secondary metabolites, enhancing our understanding of their production and function.
Traditional carbon isotope labeling techniques encounter challenges in pinpointing the specific organs responsible for the synthesis of secondary metabolites due to the highly species-specific nature of their biosynthetic pathways and transport mechanisms. Liquid chromatography-mass spectrometry (LC-MS) has risen to prominence as a pivotal analytical instrument in this arena, offering a robust method for tracking exogenous isotopes in the chemical synthesis of drugs and investigating in vivo processes such as absorption, distribution, metabolism, and excretion12. The superior sensitivity, straightforwardness, and reliability of LC-MS make it an ideal choice for monitoring the production of secondary metabolites in plants13. In recent times, LC-MS has become increasingly favored for its application in external isotope labeling techniques, which enables the evaluation of labeling efficiency across different samples. This methodology provides critical insights into the primary organs engaged in the synthesis of secondary metabolites in medicinal plants, serving as an invaluable complement to biological methods for identifying the synthesis organs of these compounds14,15. Consequently, this approach not only facilitates the comparison of labeling efficiencies among various specimens but also sheds light on the key organs implicated in the generation of plant secondary metabolites, thereby enhancing our understanding of their biosynthesis.
We introduced a novel method that combines carbon isotope labeling with LC-MS detection to identify the primary organs responsible for synthesizing secondary metabolites in medicinal plants. Paris saponin (PS) has a variety of pharmacological activities such as anticancer, immunomodulation, and anti-inflammation16, and PPY is in increasing demand17. Therefore, we used PPY seedlings as research subjects and deciphered that leaves are the primary organ to synthesize the Paris saponin VII (PS VII) (Figure 1B) by using the 13C6-Glucose labeling associated with the LC-MS method. Our approach included four different treatments involving 13C6-Glucose feeding to leaf, rhizome, and stem-vascular bundles, as well as a non-feeding control. The choice of 13C6-Glucose is strategic, as it is swiftly metabolized into acetyl coenzyme A via respiration, which then facilitates PS synthesis. Employing the natural abundance of 13C, we utilized a Gas Chromatography-Stable Isotope Ratio Mass Spectrometer (GC-IRMS) system to assess the 13C/12C ratios across various plant organs and to analyze the isotopic ion peak ratios in PS VII and Paris saponins II (PS II) (Figure 1B) molecules. Our methodology, which leverages 13C-labeled plant secondary metabolite precursors and cutting-edge mass spectrometry techniques, offers a simpler and more accurate alternative to conventional carbon isotope labeling methods. This novel approach not only deepens our comprehension of the organs involved in secondary metabolite synthesis in medicinal plants but also lays a solid groundwork for future explorations into the biosynthetic pathways of these compounds.
1. Experimental preparation
2. Carbon labeling experiment operation
3. Sampling and preparation methods
4. LC-MS setup and operation
5. Manual data acquisition, analysis, and calculation
To confirm that 13C6-Glucose supply in rhizomes was successful, we further analyzed the 13C/12C isotope ratios in rhizomes. The 13C /12C isotope ratios of Treatments 3 and 4 were much higher than those of Treatment 2 (Figure 1A). The results indicated that 13C6-Glucose from Treatment 3 and 4 entered the rhizomes through ingestion.
The ratios of 13C isotope peaks, such as (M+1) −/M−, (M+2) −/M−, (M+3) −/M−, and (M+4) −/M−, typically remain constant. Compounds labeled with exogenously added 13C have the same molecular structure, similar molecular weights, physicochemical properties, and retention times as their unlabeled counterparts. However, when these labeled compounds were analyzed using mass spectrometry, the ratios of their isotope ion peak changed. In our study, we used LC-MS to detect PS VII and PS II in four different organs of PPY in various treatments (Figure 3). Compared to Treatment 1, the results indicated a significant increase in the ratio of PS VII (M+2) −/M− in the leaves of the PPY treated with exogenous 13C (Figure 3B). Particularly in Treatment 2, where PPY leaves were sprayed with 13C6-Glucose, PS VII marked with two 13C atoms were synthesized. However, in Treatment 4, the ratio of PS VII molecules (M+2) −/M− in leaves had no significant difference between the rhizome and non-feeding treatment, and the ratios of PS VII molecules (M+1) −/M−, (M+3) −/M−, (M+4) −/M− in stem, rhizome, and root across all four treatments showed no significant differences (Figure 3A,C,D). Additionally, the ratio of PS II molecules (M+2) −/ M− increased slowly in Treatment 2 (Figure 3F). There were no notable differences in the ratios of PS II molecules (M+1) −/M− and (M+4) −/M− in leaves between Treatments 1 and 2 (Figure 3E, H), while the ratio of PS II molecules (M+3) −/M− showed a noticeable decrease in leaves in Treatment 2 compared to Treatment 1 (Figure 3G). These findings suggest that the synthesis of PS VII indeed occurs in the leaves treated with 13C6-Glucose, aligning with the known biosynthetic pathway of PSs.
Our approach suggests the leaf as the primary organ for PS VII synthesis in PPY, contrasting with the synthesis of PS II. Notably, 13C -labeled PS VII was absent in the rhizome following leaf treatment with 13C6-Glucose, implying slow transport of PS VII from leaves to rhizomes. In contrast, 13C -labeled PS II was detected in the rhizome after stem-vascular-bundle and rhizome labeling treatments, indicating possible rhizome synthesis at this stage and necessitating further exploration of PS II synthesis locations. The exclusive detection of the (M+2) −/M− ratio for PS VII molecules in leaves aligns with the metabolic fate of 13C6-Glucose; after absorption, it is metabolized via glycolysis to produce acetyl-CoA with two 13C isotopes. Considering PS as an isoprenoid compound, its biosynthesis from acetyl-CoA proceeds via either the mevalonic acid (MVA) or the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway (Figure 4), leading to (M+2) −/M− PS VII formation. Thus, our study delineates the leaf as the definitive organ for PS VII synthesis in PPY.
Figure 1: The ratio of 13C /12C isotope in rhizomes of four treatments. (A) The ratios of 13C /12C isotopes in rhizomes of Treatments 4 and 3 were much higher than that of Treatments 1 and 2, indicating that 13C6-Glucose had significantly entered the rhizomes through root feeding. Each column represents the mean (± SE) of three replicates. The letters on the columns mean significantly different in the ratio of 13C/12C isotope in four treatments (p < 0.05). Abbreviation: PS = Paris saponins. (B) The high-resolution mass spectrometry of PS VII (C51H82O21, 1030.5349) detected its negative ion with a retention time of 16.83 minutes. Due to 13C's natural abundance (with an exact molecular weight of 13.003, compared to 12C at 12.000, a range of isotope peaks including (M−), mainly (M+1)−, (M+2)−, (M+3)− and (M+4)−, appear at the same retention time as the PS VII molecular ion peak M−. These peaks were mainly due to COOH− ionization in formic acid water. An enlarged bar diagram highlights these isotope peaks. The ion current ratios of (M+1)−/M−, (M+2)−/M−, (M+3)−/M−, and (M+4)−/M− were calculated. By analyzing changes in these ratios, we could track and infer the biosynthesis of saponins. Here, M− represented the combined peak areas of ion current for (M+COOH)– and M−. Figure 1B was modified from Wen et al.24. Please click here to view a larger version of this figure.
Figure 2: 13C6-Glucose labeling and data Integration workflow. Seedlings were labeled by spraying and feeding 0.2% 13C6-glucose for 3 days; then, extracts from each organ were isotopically analyzed by LC/MS and GC/IRMS and combined with peak integration and data for organ-specific analysis of PS synthesis. (A) A schematic diagram illustrating the feeding of glucose in different organs. Treatments 1-4 were non-feeding, fed in leaf, stem-vascular-bundle, and rhizome, respectively. (B) The steps for LC-MS analysis of the extracted liquid made from the dried PPY tissue through a grinding and nitrogen-blowing instrument. Abbreviations: LC/MS = liquid chromatography-mass spectrometry; PPY = Parispolyphylla var. yunnanensis (Franch.) Hand. -Mzt.; PS = Paris saponin. Please click here to view a larger version of this figure.
Figure 3: Tracking of Paris saponin VII and Paris saponin II biosynthesis via 13C6-Glucose feeding of plant organs. (A-D) The ratio of PS VII molecules (M+1) −/M−, (M+2) −/M−, (M+3) −/M−, (M+4) −/M− in each organ of the four treatments. The ratio of PS VII molecules (M+2) −/M− increased significantly in the leaves of Treatment 2 and Treatment 3. In the stem, root, and rhizome, the ratio of PS VII molecules (M+2) −/M− showed no obvious differences between the four treatments. (E-H) The ratio of PS VII molecules (M+1) −/M−, (M+2) −/M−, (M+3) −/M−, (M+4) −/M− in each organ of the four treatments. Compared to Treatment 1, the ratios of PS II molecules (M+2) −/ M− in leaves had no difference under Treatment 2. In Treatment 2, the ratio of PS II molecules (M+1) −/M− and (M+4) −/M−have no obvious differences in leaves compared with Treatment 1. The ratios of PS II molecules (M+3) −/M− have decreased in leaves compared with Treatment 1. Paris saponin VII, PS VII. Each column represents the mean (± SE) of three replicates. "*" indicated a significant difference from non-feeding treatment (t-test at p < 0.01). Abbreviation: PS = Paris saponins. Please click here to view a larger version of this figure.
Figure 4: Description of PS VII generated by exogenous 13C6-Glucose entering the MVA pathway. Schematic diagram of the metabolism of 13C6-Glucose-labeled acetyl coenzyme A to generate PS VII molecules (M+2) −/M− via the MVA pathway. Labeled carbon is shown in red; unlabeled carbon is gray. Under the action of glycolysis, 13C6-Glucose is cleaved to two molecules of acetyl coenzyme A(M+2)-, which then generates isopentenyl pyrophosphate and dimethyl propenyl pyrophosphate through the MVA pathway, and then generates cyclic atenol via the catalytic generation of geranylgeranyl pyrophosphate synthase, farnesyl pyrophosphate synthase, squalene synthase, squalene epoxygenase, cycloatenol synthase Cycloartenol, then oxidation, decarboxylation, reduction and other reactions to obtain cholesterol, cholesterol through a series of cytochrome P450 enzymes, glycosyltransferases and furostanoid saponin 26-O-β-glucosidase of the late modification of the formation of PS VII molecules containing two labeled carbon. (M+2) – indicates that two carbon's COOH- is ionized at this point, and the number of labels for two carbon can be derived using (M+2) −/M−. Using standard protocols, the isotopic body is identified individually and the ionic currents were divided to obtain labeling data for the isotopes. The value of M− is stable. Abbreviation: PS = Paris saponins; PS VII = Paris saponin VII; MVA = Mevalonate pathway; GPPS = Geranylgeranyl pyrophosphate synthase; FPPS = Farnesyl pyrophosphate synthase; SQS = Squalene synthase; SQE = Squalene epoxygenase; CYPs = Cytochrome P450 enzymes; UGTs = Glucuronic transferase; F26G = Furostanoid saponin 26-O-β-glucosidase. Please click here to view a larger version of this figure.
The successful implementation of this protocol hinges on comprehensive research into plant physiological properties, tissues, organs, and secondary metabolites. The experimental design approach outlined in the protocol lays a robust foundation for investigating the biosynthetic pathways of plant secondary metabolites. The critical factors in this experiment are (1) determining the age of the perennial seedlings and (2) choosing the correct isotope labeling-detection timing. The medicinal plants are categorized into perennial and annual, each with different patterns of secondary metabolite synthesis and accumulation. This experiment aims to clarify the primary synthetic organs of secondary metabolites in medicinal plants by analyzing the synthesis rate of these metabolites. Therefore, it is essential to carefully select the growth years and stages that correspond to these synthesis patterns and rates.
PPY is a perennial medicinal plant, and the content of PS accumulates year by year. However, it was shown that the rate of PS synthesis did not differ from that of perennials' PPY22. At the same time, the smaller size of the 2-year-old seedlings compared to the older ones facilitates hydroponics. So, this study used 2-year-old PPY seedlings. This ensures that the selected plants exhibit the highest rate of secondary metabolite synthesis. It is crucial to acknowledge the variation in synthesis and transport rates of secondary metabolites across different species23. The optimal length for the labeling-detection period is determined by these rates. Research indicates that the content of sugar and PS in PPY leaves decreases within 3 days24, suggesting a slow transportation process for PS due to their substantial molecular weight, unlikely to be completed within this timeframe. A treatment duration shorter than a few hours might lead to inadequate synthesis and detection difficulties for labeled PS5,25. Conversely, extending the treatment beyond 3 days risks translocating PS from the leaves to the rhizome, which could distort experimental results. Therefore, a 3-day intermediate labeling period is selected to minimize organ interference – particularly for leaf spray and rhizome labeling methods – thereby ensuring more accurate experimental outcomes.
Previous isotope labeling studies on Nicotiana tabacum26,27 and Brassica napus28 had shown successful 13C6-Glucose absorption and integration into plant tissues. In our research, we focused on hydroponically grown, 2-year-old PPY seedlings, implementing 13C6-Glucose feeding treatments for leaves, rhizomes, and stem-vascular-bundles, alongside control non-feeding treatments. Using LC-MS detection, we found that by the third day after labeling, the 13C/12C ratio in the rhizomes from stem-vascular-bundle and rhizome feeding treatments was significantly higher than in the non-feeding controls, confirming effective 13C6-Glucose assimilation and the success of our labeling approach (Figure 2). In our study, we simultaneously analyzed four types of isotopic ion peak ratios for PS VII and PS II molecules in four different organs of PPY: (M+1) −/M−, (M+2) −/M−, (M+3) −/M−, and (M+4) −/M−. Importantly, we observed that in the leaf labeling treatment, the ratios of the PS VII molecule (M+2) −/M− in leaves were notably higher than in the non-feeding treatment. The ratio of PS VII molecules (M+2) −/M− in leaves under the rhizome and non-feeding treatment with no difference (Figure 3B). Additionally, compared to the non-feeding treatment, the ratio of the Paris saponins II (PS II) molecule (M+2) −/M− in leaves under leaf feeding treatment with no significant difference, and the ratios of PS II molecules (M+3) −/M− in leaves under leaf feeding treatment were lower (Figure 3G). The stem-vascular-bundle and rhizome labeling treatments exhibited significant differences in the ratios of PS II molecules (M+1) −/M− and (M+4) −/M− in rhizomes compared to the non-feeding treatment (Figure 3E, H).
When adapting this approach to other medicinal plants, it is crucial to select marker compounds tailored to the precursors of the plant's primary secondary metabolites, ensuring marker specificity. If the target compound is primarily synthesized in the stem, the labeling compound should be capable of being efficiently transported to and metabolized in the stem. Re-evaluate the synthesis pathway if expected isotopic ratios, such as (M+2) −/M− for PS VII, are absent, confirming the suitability of labeling compounds. The concentration of the labeling compound in the nutrient solution may need adjustment to ensure adequate uptake and integration into the target compounds within the desired organ. The LC-MS detection parameters may require optimization to detect the specific labeled metabolites of interest effectively. This could involve adjusting the mass spectrometry settings, such as the ionization mode, to enhance the sensitivity and specificity for the compounds unique to the plant species and organ under investigation. If the 13C/12C ratios are not detected in the rhizomes from stem-vascular-bundle and rhizome labeling treatments, the concentration of 13C6-Glucose in the Hoagland nutrient solution and the labeling duration should be increased until detection is achievable. The 13C6-Glucose feeding methods and analytical techniques established in this study should guide the analysis and interpretation of results for identifying the synthesis organs of secondary metabolites in various medicinal plants.
The 13C6-Glucose feeding and non-feeding treatments for leaves, rhizomes, and stem-vascular bundles in this experiment offer greater specificity in identifying the synthesis organs of secondary metabolites compared to traditional carbon isotope labeling methods. Nonetheless, challenges remain. One key limitation is the absence of a one-size-fits-all labeling-detection timeframe suitable for all medicinal plants. Selecting an optimal timeframe enhances labeling efficacy. Additionally, using ratios to analyze results complicates the differentiation of functional group locations in large, complex isomers. Thus, a thorough literature review and preliminary experiments are advised before employing this methodology. This strategy not only ensures accuracy and efficiency but also has significant implications for plant biology and pharmacology. Integrating this method with nuclear magnetic resonance spectroscopy, a leading technique for analyzing organic compound structures, allows for precise identification of 13C labeling locations. This method paves the way for exploring biosynthetic pathways of plant secondary metabolites, presenting a detailed and effective approach for determining organ specificity in the synthesis of secondary metabolites in medicinal plants.
The authors have nothing to disclose.
This work was funded by the National Natural Science Foundation of China's Youth Program (No. 82304670).
0.1 % Formic acid water | Chengdu Kelong Chemical Reagent Factory | 44890 | |
13C6-Glucose powder | MERCK | 110187-42-3 | |
Acetonitrile | Chengdu Kelong Chemical Reagent Factory | 44890 | |
AUTOSAMPLER VIALS | Biosharp Biotechnology Company | 44866 | |
BEH C18 column | Waters,Milfor,MA | 1.7μm,2.1*100 mm | |
CNC ultrasonic cleaner | Kunshan Ultrasound Instrument Co., Ltd | KQ-600DE | |
Compound DiscovererTM software | Thermo Scientific, Fremont,CA | 3 | |
Compound DiscovererTM software | Thermo Scientific,Fremont,CA | 3 | |
Electric constant temperature blast drying oven | DHG-9146A | ||
Electronic analytical balance | Sedolis Scientific Instruments Beijing Co., Ltd | SOP | |
Ethanol | Chengdu Kelong Chemical Reagent Factory | 44955 | |
Fully automatic sample rapid grinder | Shanghai Jingxin Technology | Tissuelyser-48 | |
Gas Chromatography-Stable Isotope Ratio Mass Spectrometer | Thermo Fisher | Delta V Advantage | |
Hoagland solution | Sigma-Aldrich | H2295-1L | |
Hydroponic tank | JRD | 1020421 | |
Isodat software | Thermo Fisher Scientific | 3 | |
Liquid chromatography high-resolution mass spectrometry | Agilent Technology | Agilent 1260 -6120 | |
Nitrogen manufacturing instrument | PEAK SCIENTIFIC | Genius SQ 24 | |
Organic phase filter | Tianjin Jinteng Experimental Equipment Co., Ltd | 44890 | |
Oxygen pump | Magic Dragon | MFL | |
Quantum sensor | Highpoint | UPRtek | |
Scalpel | Handskit | 11-23 | |
Sprinkling can | CHUSHI | WJ-001 | |
Xcalibur software | Thermo Fisher Scientific | 4.2 |